Literature DB >> 12544683

Estrogen-related pancreatitis in the setting of normal plasma lipids: case report.

William E D Blake1, Meron E Pitcher.   

Abstract

A case of recurrent acute pancreatitis occurring in conjunction with intermittently used estrogen therapy over 7 years is presented. Estrogens have been associated with pancreatitis in the past, and a causal link involving elevated plasma triglyceride levels has usually been assumed. The current case is distinct in that the plasma lipids of this patient have always been normal, suggesting that a different mechanism must be responsible for the onset of pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544683     DOI: 10.1097/00042192-200310010-00015

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  5 in total

1.  All-trans-retinoic acid induced acute pancreatitis: a single or multifactorial association?

Authors:  Rodrigo Lopes da Silva
Journal:  Int J Hematol       Date:  2011-04-07       Impact factor: 2.490

2.  Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a prospective cohort study.

Authors:  Viktor Oskarsson; Nicola Orsini; Omid Sadr-Azodi; Alicja Wolk
Journal:  CMAJ       Date:  2014-01-27       Impact factor: 8.262

Review 3.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction.

Authors:  Jee Lee; Ira J Goldberg
Journal:  J Clin Lipidol       Date:  2008-02       Impact factor: 4.766

5.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.